ACG clinical guideline: evaluation of abnormal liver chemistries
Abstract
Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elevation of liver enzymes, namely aminotransferases, is associated with increased liver-related mortality.
“Elevation of liver enzymes, namely aminotransferases, is associated with increased liver-related mortality.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [21]
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,805 · see citing works
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works
Chronic hepatitis B: Update 2009 #
Lok, A. S.-F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,836 · see citing works
Liver enzyme alteration: a guide for clinicians
Giannini, E. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040752 · Cited by 2,022 · see citing works
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2008) · Hepatology · doi:10.1002/hep.22742 · Cited by 2,004 · see citing works
TRANSAMINASE ACTIVITY IN HUMAN BLOOD
Karmen, A., Wröblewski, F., & LaDue, J. S. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103055 · Cited by 1,715 · see citing works
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
Rubio‐Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.79 · Cited by 1,681 · see citing works
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445 · see citing works
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07486.x · Cited by 1,359 · see citing works
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241 · see citing works
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
Pratt, D. S., & Kaplan, M. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421707 · Cited by 1,203 · see citing works
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072 · see citing works
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,018 · see citing works
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991 · see citing works
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Pürschel, A., Stremmel, W., Häussinger, D., & Strohmeyer, G. W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 885 · see citing works
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860 · see citing works
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
Kim, W. R., Flamm, S. L., Bisceglie, A. M. D., & Bodenheimer, H. C. (2008) · Hepatology · doi:10.1002/hep.22109 · Cited by 858 · see citing works
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823 · see citing works
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 818 · see citing works
Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011) · Hepatology · doi:10.1002/hep.24330 · Cited by 721 · see citing works
Hyeon, C. K., Chung, M. N., Jee, S. H., Kwang, H. H., Oh, D. K., & Suh, I. (2004) · BMJ · doi:10.1136/bmj.38050.593634.63 · Cited by 598 · see citing works
AGA technical review on the evaluation of liver chemistry tests
Green, R. M., & Flamm, S. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.36061 · Cited by 586 · see citing works
AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Sheth, S. G., Flamm, S. L., Gordon, F. D., & Chopra, S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.044_c.x · Cited by 583 · see citing works
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2027 · Cited by 568 · see citing works
Menon, K. V. N., Shah, V. H., & Kamath, P. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmra020282 · Cited by 554 · see citing works
Lee, W. M., Stravitz, R. T., & Larson, A. M. (2011) · Hepatology · doi:10.1002/hep.25551 · Cited by 549 · see citing works
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524 · see citing works
Celaya, F. B. (1989) · PubMed · Cited by 504 · see citing works
HIGH AST/ALT RATIO MAY INDICATE ADVANCED ALCOHOLIC LIVER DISEASE RATHER THAN HEAVY DRINKING
Nyblom, H. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh074 · Cited by 477 · see citing works
The SGOT/SGPT ratio?An indicator of alcoholic liver disease
Cohen, J. A., & Kaplan, M. M. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01324898 · Cited by 451 · see citing works
A Practice Guideline on Wilson Disease
Roberts, E. A., & Schilsky, M. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50252 · Cited by 450 · see citing works
Alpha 1 -Antitrypsin Deficiency — A Model for Conformational Diseases
Carrell, R. W., & Lomas, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010772 · Cited by 447 · see citing works
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2050 · Cited by 439 · see citing works
Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., Neitzel, S. M., & Ward, J. W. (2008) · PubMed · Cited by 364 · see citing works
Muscular exercise can cause highly pathological liver function tests in healthy men
Pettersson, J., Hindorf, U., Persson, P., Bengtsson, T., Malmqvist, U. P., Werkström, V., & Ekelund, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03001.x · Cited by 357 · see citing works
Ruhl, C. E., & Everhart, J. E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 350 · see citing works
Ioannou, G. N., Boyko, E. J., & Lee, S. P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00341.x · Cited by 327 · see citing works
Alter, M. J., Kuhnert, W. L., & Finelli, L. (2003) · PubMed · Cited by 321 · see citing works
Review article: herbal and dietary supplement hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12109 · Cited by 321 · see citing works
Chand, N., & Sanyal, A. J. (2006) · Hepatology · doi:10.1002/hep.21480 · Cited by 319 · see citing works
Rein, D. B., Smith, B. D., Wittenborn, J. S., Lesesne, S. B., Wagner, L. D., Roblin, D. W., Patel, N., Ward, J. W., & Weinbaum, C. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00378 · Cited by 302 · see citing works
Piton, A., Poynard, T., Imbert‐Bismut, F., Khalil, L., Delattre, J., Pélissier, É., Sansonetti, N., & Opolon, P. (1998) · Hepatology · doi:10.1002/hep.510270505 · Cited by 295 · see citing works
Zeuzem, S., Diago, M., Gane, E. J., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.050 · Cited by 246 · see citing works
Erlinger, S., Arias, I. M., & Dhumeaux, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.047 · Cited by 242 · see citing works
Human Babesiosis in New York State
White, D. J., Talarico, J., Chang, H.-G., et al. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.19.2149 · Cited by 238 · see citing works
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Mozaffarian, D., & Lee, S. P. (2006) · Hepatology · doi:10.1002/hep.21171 · Cited by 220 · see citing works
Lee, D.-H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl086 · Cited by 219 · see citing works
Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review
Fairbanks, K. D., & Tavill, A. S. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01955.x · Cited by 210 · see citing works
Serum aminotransferase activity and mortality risk in a United States community
Lee, T. H., Kim, W. R., Benson, J. T., Therneau, T. M., & Melton, J. L. (2008) · Hepatology · doi:10.1002/hep.22090 · Cited by 208 · see citing works
Does This Patient With Liver Disease Have Cirrhosis?
Udell, J. A., Wang, C. S., Tinmouth, J., FitzGerald, J. M., Ayas, N., Simel, D. L., Schulzer, M., Mak, E., & Yoshida, E. M. (2012) · JAMA · doi:10.1001/jama.2012.186 · Cited by 201 · see citing works
Serum Gamma-Glutamyl Transpeptidase Activity as an Indicator of Disease of Liver, Pancreas, or Bone
Lum, G., & Gambino, S. R. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.4.358 · Cited by 190 · see citing works
Acute Hepatitis C: A Systematic Review.
Kamal, S. M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01825.x · Cited by 181 · see citing works
Lee, J. K., Shim, J. H., Lee, H. C., Lee, S. H., Kim, K. M., Lim, Y., Chung, Y., Lee, Y. S., & Suh, D. J. (2009) · Hepatology · doi:10.1002/hep.23505 · Cited by 180 · see citing works
Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
Beuers, U. H., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E., Lindor, K. D., Ma, X., Mackay, I. R., Parés, A. R., Tanaka, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.031 · Cited by 173 · see citing works
Tapper, E. B., Castéra, L., & Afdhal, N. H. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.039 · Cited by 164 · see citing works
Upper Limits of Normal for Alanine Aminotransferase Activity in the United States Population
Ruhl, C. E., & Everhart, J. E. (2011) · Hepatology · doi:10.1002/hep.24725 · Cited by 158 · see citing works
Alanine Aminotransferase Levels: What's Normal?
Kaplan, M. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00012 · Cited by 139 · see citing works
Kaplan, M. M. (1972) · New England Journal of Medicine · doi:10.1056/nejm197201272860407 · Cited by 135 · see citing works
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity # †
Gurrin, L. C., Bertalli, N. A., Dalton, G. W., Osborne, N. J., Constantine, C. C., McLaren, C. E., English, D. R., Gertig, D. M., Delatycki, M. B., Nicoll, A., et al. (2009) · Hepatology · doi:10.1002/hep.22972 · Cited by 127 · see citing works
Ceriotti, F., Henny, J., Queraltó, J. M., Ziyu, S., Özarda, Y., Chen, B., Boyd, J. C., & Panteghini, M. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.315 · Cited by 121 · see citing works
Neuschwander‐Tetri, B. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.131 · Cited by 120 · see citing works
Benign Postoperative Intrahepatic Cholestasis
Schmid, M., Hefti, M., GATTIKER, R. I., et al. (1965) · New England Journal of Medicine · doi:10.1056/nejm196503182721101 · Cited by 106 · see citing works
Arndt, V., Brenner, H., Rothenbacher, D., Zschenderlein, B., Fraisse, E., & Fliedner, T. M. (1998) · International Archives of Occupational and Environmental Health · doi:10.1007/s004200050299 · Cited by 96 · see citing works
The Myth of Statin-Induced Hepatotoxicity
Bader, T. F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.102 · Cited by 82 · see citing works
Almeida, N. E. C., Vanga, R. R., Theethira, T. G., Rubio‐Tapia, A., Murray, J. A., Villafuerte-Gálvez, J., Bonder, A., Mukherjee, R., Hansen, J., Dennis, M. D., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.192 · Cited by 81 · see citing works
Regev, A., Guaqueta, C. B., Molina, E. G., et al. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226387.56612.1e · Cited by 81 · see citing works
Serum gamma-glutamyl transpeptidase and chronic alcoholism
Moussavian, S. N., Becker, R. C., Piepmeyer, J. L., Mezey, E., & Bozian, R. C. (1985) · Digestive Diseases and Sciences · doi:10.1007/bf01347885 · Cited by 76 · see citing works
Severe Postoperative Hyperbilirubinemia Simulating Obstructive Jaundice
Kantrowitz, P. A., Jones, W. A., Greenberger, N. J., et al. (1967) · New England Journal of Medicine · doi:10.1056/nejm196703162761101 · Cited by 71 · see citing works
Nomura, F., Ohnishi, K., Satomura, Y., et al. (1986) · PubMed · Cited by 71 · see citing works
Variability in the upper limit of normal for serum alanine aminotransferase levels
Dutta, A., Saha, C., Johnson, C. S., et al. (2009) · Hepatology · doi:10.1002/hep.23200 · Cited by 70 · see citing works
Fraser, A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Hepatology · doi:10.1002/hep.21667 · Cited by 66 · see citing works
Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management
Vierling, J. M. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.012 · Cited by 65 · see citing works
Nutt, A., Hassan, H. A.-H., Lindsey, J. L., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00381-8 · Cited by 56 · see citing works
Clinical significance of an increased or decreased serum alkaline phosphatase level.
Wolf, P. L. (1978) · PubMed · Cited by 53 · see citing works
Scharschmidt, B. F., Blanckaert, N. J. C., Farina, F., et al. (1982) · Gut · doi:10.1136/gut.23.8.643 · Cited by 52 · see citing works
Variations in the Phosphatase Activity of the Blood in Disease.
Roberts, W. M. (1930) · PubMed Central · Cited by 51 · see citing works
Jüngst, C., & Lammert, F. (2013) · Digestive Diseases · doi:10.1159/000347210 · Cited by 48 · see citing works
Physical Examination of the Liver
Naylor, C. D. (1994) · JAMA · doi:10.1001/jama.1994.03510470063036 · Cited by 46 · see citing works
Noninvasive assessment of liver function
Helmke, S. M., Colmenero, J., & Everson, G. T. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000167 · Cited by 45 · see citing works
Wejstål, R., Hansson, G. C., Lindholm, A., et al. (1988) · Vox Sanguinis · doi:10.1111/j.1423-0410.1988.tb05083.x · Cited by 43 · see citing works
Watson, K. J. R., & Gollan, J. L. (1989) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(89)90004-3 · Cited by 41 · see citing works
Unconjugated hyperbilirubinemia in the absence of overt hemolysis
Levine, R. A., & Klatskin, G. (1964) · The American Journal of Medicine · doi:10.1016/0002-9343(64)90102-0 · Cited by 40 · see citing works
Clinical evaluation of liver size and hepatic scintiscan
Peternel, W. W., Schaefer, J. W., & Schiff, L. (1966) · Digestive Diseases and Sciences · doi:10.1007/bf02233628 · Cited by 37 · see citing works
Correia, J. P., Alves, P. S., & Camilo, E. A. (1981) · Digestive Diseases and Sciences · doi:10.1007/bf01391646 · Cited by 37 · see citing works
THE SIGNIFICANCE OF A PALPABLE LIVER
Rosenfield, A. T., Laufer, I., & Schneider, P. B. (1974) · American Journal of Roentgenology · doi:10.2214/ajr.122.2.313 · Cited by 32 · see citing works
Liver function test abnormalities in early Lyme disease
Kazakoff, M. A. (1993) · Archives of Family Medicine · doi:10.1001/archfami.2.4.409 · Cited by 28 · see citing works
Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy
Keeffe, E. B., Sunderland, M. C., & Gabourel, J. D. (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01300258 · Cited by 28 · see citing works
Nutt, A., & Raufman, J. (1999) · Digestive Diseases · doi:10.1159/000016901 · Cited by 26 · see citing works
The rational clinical examination. Physical examination of the liver
Naylor, C. D. (1994) · JAMA · doi:10.1001/jama.271.23.1859 · Cited by 26 · see citing works
“Isolated” Elevation of Alkaline Phosphatase
Lieberman, D. A., & Phillips, D. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199008000-00012 · Cited by 24 · see citing works
Kim, H., Lee, S.-H., & Lee, D. (2014) · Lung · doi:10.1007/s00408-014-9616-3 · Cited by 15 · see citing works
Kawachi, I., Robinson, G., & Stace, N. H. (1990) · PubMed · Cited by 13 · see citing works
Liver function testing in a working population: three strategies to reduce false-positive results.
Wright, C., Jc, R., & Jh, B. (1988) · PubMed · Cited by 12 · see citing works
Matsushita, M., & Komoda, T. (2011) · PubMed · Cited by 9 · see citing works
[Acute cholestatic hepatitis caused by simvastatine in a 67-year-old patient].
Łata, S., & Chudy, B. (2006) · PubMed · Cited by 5 · see citing works
[Parotid hypertrophy and Dupuytren's contracture in liver cirrhosis].
Wegmann, T. (1960) · PubMed · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021 · see citing works
A Longitudinal Big Data Approach for Precision Health
Schüssler-Fiorenza Rose, S. M., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., Dagan-Rosenfeld, O., Ganz, A. B., Dunn, J., Hornburg, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0414-6 · Cited by 494 · see citing works
Long, M. T., Noureddin, M., & Lim, J. K. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.023 · Cited by 299 · see citing works
Self-citationHajifathalian, K., Torabi Sagvand, B., & McCullough, A. J. (2019) · Hepatology · doi:10.1002/hep.30226 · Cited by 128 · see citing works
Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease
Verweij, N., Haas, M. E., Nielsen, J. B., Sosina, O. A., Kim, M., Akbari, P., De, T., Hindy, G., Bovijn, J., Persaud, T., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2117872 · Cited by 127 · see citing works
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy
McConnell, M. J., Kawaguchi, N., Kondo, R., Sonzogni, A., Licini, L., Valle, C., Bonaffini, P. A., Sironi, S., Alessio, M. G., Previtali, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.050 · Cited by 111 · see citing works
“The upper limit of normal for ALT was defined as 33 IU/L for males and 25 IU/L for females.(24) Within this sample, thromboelastography (TEG) was performed for the 48 patients in the intensive care unit.”
Udompap, P., Therneau, T. M., Canning, R. E., Benson, J. T., & Allen, A. M. (2023) · Hepatology · doi:10.1002/hep.32739 · Cited by 37 · see citing works
Tran, G.-B., Dam, S.-M., & Le, N.-T. T. (2018) · International Journal of Hepatology · doi:10.1155/2018/9383950 · Cited by 35 · see citing works
ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis
Yao, Q., Wang, B., Yu, J., Pan, Q., Yu, Y., Feng, X., Chen, W., Yang, J., Gao, C., & Cao, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.006 · Cited by 24 · see citing works
Yang, M., Su, W., Li, H., Li, L., An, Z., Xiao, F., Liu, Y., Zhang, X., Liu, X., Guo, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115473 · Cited by 23 · see citing works
Emre, H. O., Ozturk, O. G., Coskun, A., Yucel, D., Yazici, C., Serteser, M., Senes, M., Deniz, L., Arslan, F. D., Cubukcu, H. C., et al. (2021) · Biochemia Medica · doi:10.11613/bm.2021.010705 · Cited by 17 · see citing works
Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Ben-Haroush Schyr, R., Romano-Zelekha, O., & Ben-Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051144 · Cited by 13 · see citing works
Bourcigaux, N., Dubost, E., Buzzi, J.-C., Donadille, B., Corpechot, C., Poujol-Robert, A., & Christin-Maitre, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad108 · Cited by 8 · see citing works
- Authors
- Kwo, P. Y., Cohen, S. M., & Lim, J. K.
- Affiliations
- Stanford Medicine (US)
- University Hospitals of Cleveland (US)
- Yale University (US)
- Corresponding author
- Kwo, Paul Y
- Venue
- American Journal of Gastroenterology
- Published
- 2017-01
- Volume
- 112
- Issue
- 1
- Pages
- 18-35
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2563118732
- Cited by
- 1,222
- References
- 98
- Citations by year
- 2026: 161 · 2025: 159 · 2024: 176 · 2023: 158 · 2022: 144 · 2021: 141 · 2020: 116 · 2019: 81 · 2018: 62 · 2017: 18 · 2016: 1 · 2014: 1 · 2012: 1
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, hepatocyte injury, cholestatic liver injury, viral hepatitis screening, non-alcoholic fatty liver disease, alcoholic liver disease, hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, alpha-1 antitrypsin deficiency, primary biliary cirrhosis, primary sclerosing cholangitis, liver biopsy, liver-related mortality
- MeSH terms
- Alanine Transaminase, Alkaline Phosphatase, Aspartate Aminotransferases, Bilirubin, Biopsy, Cholestasis, Hemochromatosis, Hepatitis, Viral, Human, Hepatolenticular Degeneration, Humans, Liver, Liver Diseases, Liver Diseases, Alcoholic, Hepatitis, Autoimmune, alpha 1-Antitrypsin Deficiency, Chemical and Drug Induced Liver Injury, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review